GRN and Parkinson disease: Collectively, therefore, it seems PGRN expression and function may be implicated in modulation of PD onset and/or progression, although the precise mechanism linking this to disease is currently unknown, but we posit is associated with neuroinflammation and lysosomal dysfunction that contributes to α-syn pathology.